期刊文献+

巨块肝癌分靶区计划设计与评估

Designing and evaluating the treatment plans using divided targets for stereotactic body radiotherapy of massive liver cancer tumors
下载PDF
导出
摘要 目的为了提高肿瘤的覆盖率,减小漏照体积,探讨对巨块肝癌分靶区治疗计划进行设计。方法选取巨块肝癌2例,首先把计划靶区(PTV)作为一个靶区进行计划设计;然后进行分靶区计划设计,把PTV分成3个子靶区,分别为PTV1、PTV2和PTV3。PTV1和PTV3为计划设计区,PTV2是PTV1与PTV3之间的间隔区。然后对这两种方法设计出来的结果进行对比和评估。结果分靶区与单靶区计划设计相比,两个病例的肿瘤覆盖率分别提高了15.94%和32.49%,靶区的漏照射体积减少135.78cc(78.20%)和227.37cc(97.02%)。结论分靶区计划设计的方案解决了巨块肝癌计划设计困难和边缘剂量不足的问题,大大提高了肿瘤的覆盖率。分靶区计划设计增加了患者的治疗次数,延长了治疗时间。 [ Objective ] In order to improve coverage to tumors and decrease the mis-irradiated volume, we discussed the design of using divided targets for the treatment of massive liver cancer tumors. [ Methods ] We selected two cases of massive liver cancer.At first, we used the PTV1 as a single target for the treatment; then we used the divided targets for the treatment plan.We divided the planning target volume (PTV) into three sub-targets: PTV1, PTV2 and PTV3.The PTV1 and PTV3 were the regions for which treatment plans were designed, and the PTV2 was the spacer region between PTV1 and PTV3.For both methods, we compared and evaluated the results ofthem. [ Results ] Compared with the plans for a single target, the plans for divided targets increased 15.94% and 32.49% of the tumor coverage for two cases, respectively. The mis-irradiated volume in the target area decreased 135.78 cc (73.77%) and 227.37 (97.02%). [ Conclusion ] Plans that used divided targets overcame the challenge of designing treatment plans for massive liver cancer tumors, and resolved the problem of dose shortage to the edge of tumor.These plans greatly improved tumor coverage, however, increased the treatment time for patients.
机构地区 解放军第
出处 《中国医学工程》 2013年第7期1-2,5,共3页 China Medical Engineering
基金 吴阶平医学基金会临床科研专项资助基金(320.6750.12356)
关键词 巨块肝癌 分靶区 计划设计 massive liver cancer tumor divided targets designing treatment plan
  • 相关文献

参考文献9

  • 1徐慧军,李玉,张素静,吴昊,刘小亮.CT引导下在肝脏中单针植入双金标用于射波刀SBRT治疗[J].中国医学工程,2013,21(1):1-3. 被引量:2
  • 2Mizowaki T,Hatano K,Hiraoka M.Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer[J].J Radiat Res,2012,53(4):608-614.
  • 3徐慧军,李玉,张素静.肝脏肿瘤中的金标移位统计与风险探讨[J].中华临床医师杂志(电子版),2013,7(1):178-179. 被引量:5
  • 4Sharma BA,Singh Tl',Singh LJ,et al.BiologicaI effective doses in the intracavitary high dose rate brachytherapy of cervical cancer[J].J Contemp Brachytherapy,2011,3(4):188-192.
  • 5Benedict SH,Yenice KM,Followill D,et al.Stereotactic body radiation therapy: the report of AAPM Task Group 101[J].Med Phys,2010,37(8):4078-4101.
  • 6Johansson Seechurn CC,Parisel SL,Colacot TJ.Air-stable Pd(R- allyl)LC1 (L= Q-Phos, P(t-Bu)3, etc.) systems for C-C/N couplings: insight into the structure-activity relationship and catalyst activation pathway[J].J Org Chem,2011,76(19):7918-7932.
  • 7Chang DS,Bartlett GK,Das IJ,et al.Beam angle selection for intensity-modulated radiotherapy .(IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?[J].Clin Transl Oncol,2013.
  • 8Jung SH,Yoon SM,Park SH,et ahFour-dimensional dose evaluation using deformable image registration in radiotherapy for liver cancer[J].Med Phys,2013,40(1):011706.
  • 9Miszczyk L,Tukiendorf A,Jochymek B.Linac based radical radioablation of liver tumors[J].Technol Cancer Res Treat,2013,12(3):225-232.

二级参考文献21

  • 1梁军,李玉,柴广金.图像引导技术与肝胆胰肿瘤放射治疗//李玉.肝胆胰恶性肿瘤的微创技术.北京:科学技术技术出版社,2009:88-97.
  • 2Jae Hyun Kim,Seong Sook Hong,Jung Hoon Kim,et aI.Safety and efficacy of ultrasound-guide fiducial marker implantation for CyberKnife radiation therapy[J].Korean J Radio1,2012:307-313.
  • 3Devanand Anantham,David Feller-Kopman,Lakshmi N.Shanmugham,et aI.Elet:tromagnetic navigation bronhoscopy- guided fiducial pla:ement for robotic syereotactic radiosurgery of lun t umors[J].Chest,2007,132(3):930-935.
  • 4Mallarajapatna GJ,Susheela SP,Kallur KG,et al.lmage guided internal fidueial placement for stereotactic radiosurgery (CyberKnife) [J].Indian J Radiol Imaging ,2011,21:3-5.
  • 5Kothary N,Heit JJ,Louie JD,et al.Safety and efficacy of percutaneous fiduclal marker implantation for image-guide radiation[J].J Yasc Interv Radiol,2009,20(2):2B5 -2B9.
  • 6Nishita Kothary,Sonja Dieterich,John D Louie,et al.Percutaneous implantation of fiducial markers for imaging-guided radiation therapy[J].AJR, 2009,192:1090-1095.
  • 7Sotiropoulou E, Stathochristopoulou |, Stathopoulos K, et al.CT- guided fiducial placement for cyberknife stereotactic radiosurgery: an initial experience[J].Cardiovasc Intervent Radiol,2010,33:586-589.
  • 8Christopher Lee.Airway Migration of Lung Fiducial Marker After Autologous Blood-Patch Injeetion[J].Cardiovase Intervent Radiol,2012,35:711-713.
  • 9] Kupelian P,Forbes A,Willoughby T, et al.lmplantation and stability of metallic fiducials within pulmonary lesions[J].Int J Radiat Oncol Biol Phys,2007,69:777-785.
  • 10Christopher Lee.Airway Migration of Lung Fiducial Marker After Autologous Blood–Patch Injection[J].CardioVascular and Interventional Radiology.2012(3)

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部